As we welcome the new year, CZI Co-Founder and Co-CEO Priscilla Chan sat down with Patricia Brennan, vice president of science technology and general manager for science at CZI, and Shana Kelley, president of the Chan Zuckerberg Biohub Chicago, to reflect on the progress made over the past year in building tools to better understand and measure disease — and the exciting work still ahead.
From releasing a platform for researchers and biologists to easily access state-of-the-art AI-powered cell models to debuting the Chicago Biohub’s first-of-its-kind sensor to monitor inflammation in real-time, the conversation highlighted tangible work towards accelerating biomedical research and demonstrating progress toward CZI’s mission to cure, prevent or manage all diseases by the end of the century.